http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2705570-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99cd2888b2026702c522c60b1544ff90 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate | 2018-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43b033ae20f88442d573d9b10f6d80c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e08b54018cc3d9c715544a278b6db64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9a908ce8802b12afe73c8f875037a40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feeeb50a67e848cb61f469de03485bcc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f81c082d9885d73e0038c042a53e265 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fbdb4895e4a928d1cfa61f2d8097b2d |
| publicationDate | 2019-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2705570-C1 |
| titleOfInvention | Method for predicting progressive liver fibrosis and selecting a combination of preparations for antiretroviral therapy in co-infection of hiv/hcv |
| abstract | FIELD: medicine.SUBSTANCE: invention refers to medicine and aims at selecting antiretroviral therapy for co-infection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) taking into account the threat of progressing hepatic fibrosis. Using a set of risk factors of progressive liver fibrosis in patients with HIV/HCV co-infection, liver elastometry parameters and immunological data, the high risk index of a progressive liver fibrosis is calculated by the equation: HRI=4.070+0.099*kPa+0.476*CD4-0.518*IRI, where kPa is the initial elastometry index, CD4 is the CD3+CD4+absolute number of blood cells/ml, the IRI is the immunoregulatory index. At values of HRI≤180 conclude that patient belongs to the risk group of progressive liver fibrosis.EFFECT: method enables timely selection of therapy.1 cl, 3 dwg, 3 tbl, 3 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2774596-C1 |
| priorityDate | 2018-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.